An in-depth look to GENERAL BIOLOGICAL CORP operating, investing, and financing activities

4117 free cash flow for H2 23 is -55.4 M TWD. For 2023, 4117 free cash flow was -198.07 M TWD and operating cash flow was 225.94 M TWD.